BackComera Life Sciences Holdings- Warrants (19/05/2027) Overview

Comera Life Sciences Holdings- Warrants (19/05/2027) Net Tangible Assets

Latest net tangible assets for CMRAW: $-4.2M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-4.22M
23.12% YoYΔ $-792594.00 vs prior year quarter

Peer average

Loading

Comera Life Sciences Holdings- Warrants (19/05/2027) Net Tangible Assets History

Loading

Comera Life Sciences Holdings- Warrants (19/05/2027) vs. peers: Net Tangible Assets Comparison

Loading

Comera Life Sciences Holdings- Warrants (19/05/2027) Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Comera Life Sciences Holdings- Warrants (19/05/2027) (CMRAW) FAQ

As of the most recent data (September 2023), CMRAW shows a net tangible assets of $-4.2M. That compares with $-3.4M in the prior-year period — down 23.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CMRAW's net tangible assets is now $-4.2M (was $-3.4M) — a 23.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Comera Life Sciences Holdings- Warrants (19/05/2027) is outperforming or lagging.

Tracking CMRAW's net tangible assets over time shows whether Comera Life Sciences Holdings- Warrants (19/05/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $-4.2M That compares with $-3.4M in the prior-year period — down 23.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Comera Life Sciences Holdings- Warrants (19/05/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $-4.2M) with ownership activity and broader fundamentals.